Search results for "Depressant"

showing 10 items of 204 documents

In search for predictive biomarkers: dissecting the molecular pathways in brain and blood underlying poor and good antidepressant treatment response

2018

Major depression poses a serious social and economic threat to modern societies, as it accounts for more lost productivity compared with any other disorder. There are currently two major problems calling for innovative research approaches: 1. The absence of biomarkers predicting antidepressant response and 2. The lack of conceptually novel antidepressant compounds. Identification of biomarkers could allow patient stratification and enable the selection of pathophysiologically distinct patient subgroups to allow optimized treatment choices based on biology. In search for conceptually novel antidepressants, the hippocampal dentate gyrus is a region of particular interest, as there is a large …

Pharmacologybusiness.industryDentate gyrusNeurogenesisHippocampal formationBioinformaticsParoxetinePsychiatry and Mental healthNeurologymedicineAntidepressantAnxietyPharmacology (medical)Neurology (clinical)medicine.symptombusinessBiological Psychiatrymedicine.drugWhole bloodBehavioural despair testEuropean Neuropsychopharmacology
researchProduct

Comparison of Paroxetine and Maprotiline in Minor Depression

1994

Whilst the efficacy of paroxetine has been demonstrated in MDD, its clinical utility in minor depression has not been established. This study assesses the antidepressant efficacy of paroxetine in patients meeting RDC criteria for minor depression. All patients scored 13 points on the 17-item Hamilton Depression Rating Scale (HAMD) at baseline. After a 3 day washout period, patients were randomised to receive paroxetine 20–40mg/day or maprotiline 100-150mg/day, dose being titrated according to clinical response after 3 weeks treatment at the lower doses. Assessments conducted at baseline (day 0) and at weekly intervals for 6 weeks included the 17-item HAMD, the Montgomery-Asberg Depression R…

Pharmacologymedicine.medical_specialtyAntidepressant efficacyIntention-to-treat analysisbusiness.industryParoxetinePsychiatry and Mental healthRating scaleInternal medicineHamdmedicineClinical Global ImpressionPsychiatrybusinessMaprotilineDepression (differential diagnoses)medicine.drugNeuropsychopharmacology
researchProduct

Caffeine as a Gelator

2016

Caffeine (a stimulant) and ethanol (a depressant) may have opposite effects in our body, but under in vitro conditions they can “gel” together. Caffeine, being one of the widely used stimulants, continued to surprise the scientific community with its unprecedented biological, medicinal and physicochemical properties. Here, we disclose the supramolecular self-assembly of anhydrous caffeine in a series of alcoholic and aromatic solvents, rendering a highly entangled microcrystalline network facilitating the encapsulation of the solvents as illustrated using direct imaging, microscopy analysis and NMR studies. Peer reviewed

Polymers and Plasticsmedicine.drug_classSupramolecular chemistryBioengineeringDirect imaging02 engineering and technology010402 general chemistry01 natural sciencessupramolecular chemistrylcsh:ChemistryBiomaterialschemistry.chemical_compoundAnhydrous caffeinelcsh:General. Including alchemySupramolecularlcsh:Inorganic chemistrysupramolekulaarinen kemiamedicineOrganic chemistrylcsh:Scienceta116caffeinegeelitsolid state NMREthanolta114ChemistryCommunicationOrganic Chemistry021001 nanoscience & nanotechnologygelslcsh:QD146-1970104 chemical sciences3. Good healthMicrocrystallinelcsh:QD1-999kofeiiniAromatic solventslcsh:QDepressant0210 nano-technologyCaffeinelcsh:QD1-65Gels Caffeine SupramolecularGels
researchProduct

EPA-0703 – Performance of the hamilton depression rating subscales to predict antidepressant treatment response in the early course of treatment

2014

Early improvement ( EI ), i.e. a symptom reduction from baseline of at least 20% after 2 weeks, has been proven to be a clinically useful predictor for later treatment outcome. In most studies EI is identified by using the sum score of the Hamilton Depression Rating Scale (HAMD). Several unidimensional subscales of the HAMD exist, which have proven to be an economic measure of treatment change. Their ability to detect onset of improvement in comparison to the full HAMD has not been researched yet. The present study investigated in patients with major depression (MD) (1) whether the HAMD subscales are a valid and economic option to predict antidepressant treatment response in the early cours…

Predictive validityPsychiatry and Mental healthReceiver operating characteristicRating scaleMirtazapineHamdmedicineAntidepressantPsychologyParoxetineDepression (differential diagnoses)medicine.drugClinical psychologyEuropean Psychiatry
researchProduct

Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynor…

2021

Delayed onset of antidepressant action is a shortcoming in depression treatment. Ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) have emerged as promising rapid-acting antidepressants. However, their mechanism of action remains unknown. In this study, we first described the anxious and depression-prone inbred mouse strain, DBA/2J, as an animal model to assess the antidepressant-like effects of ketamine and HNK in vivo. To decode the molecular mechanisms mediating HNK's rapid antidepressant effects, a longitudinal cerebrospinal fluid (CSF) proteome profiling of its acute and sustained effects was conducted using an unbiased, hypothesis-free mass spectrometry-based proteomics app…

ProteomicsNeurophysiology and neuropsychologyanimal structuresHydroxynorketaminePhysiologyGlucocorticoid receptor signalingAntidepressantCSFNeurosciences. Biological psychiatry. NeuropsychiatryBiologyPharmacologyProteomicsBiochemistryCellular and Molecular NeuroscienceEndocrinologyGlucocorticoid receptorNeurotrophic factorsmedicineOriginal Research ArticleKetamine ; CSF ; Antidepressant ; (2R6R)-Hydroxynorketamine ; Glucocorticoid receptor signaling ; ProteomicsRC346-429Molecular BiologyPI3K/AKT/mTOR pathwayEndocrine and Autonomic SystemsQP351-495Mechanism of action(2R6R)-Hydroxynorketamineembryonic structuresAntidepressantKetamineNeurology. Diseases of the nervous systemmedicine.symptomSignal transductionRC321-571Neurobiology of Stress
researchProduct

Reliability and Validity of the Assessment of Antidepressant Effects

1988

Psychiatric Status Rating ScalesDepressive DisorderPsychiatry and Mental healthbusiness.industryHumansAntidepressantMedicinePharmacology (medical)General MedicinebusinessAntidepressive AgentsReliability (statistics)Reliability engineeringPharmacopsychiatry
researchProduct

Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydro…

2008

Human diploid fibroblasts (HDFs) exposed to subcytotoxic stresses under H2O2, tert-butylhydroperoxide (t-BHP), and ethanol (EtOH) undergo stress-induced premature senescence (SIPS) characterized by many biomarkers of HDFs replicative senescence. Among these biomarkers are a growth arrest, an increase in the senescence-associated β-galactosidase activity, a senescent morphology, an overexpression of p21waf-1 and the subsequent inability to phosphorylate pRb, the presence of the common 4977-bp mitochondrial deletion, and an increase in the steady-state level of several senescence-associated genes such as apolipoprotein J (apo J). Apo J has been described as a survival gene against cytotoxic s…

SenescenceCell SurvivalGene ExpressionSimian virus 40Biologymedicine.disease_causeTritiumBiochemistrytert-ButylhydroperoxideGene expressionmedicineHumansOsteonectinRNA MessengerCytotoxicityCells CulturedCellular SenescenceCell Line TransformedGlycoproteinsClusterinEthanolCentral Nervous System DepressantsCell BiologyTransfectionOriginal ArticlesFibroblastsbeta-GalactosidaseMolecular biologyRecombinant ProteinsFibronectinsOxidative StressClusterinbiology.proteinPhosphorylationMitogensCell agingOxidative stressMolecular ChaperonesThymidineCell Stress and Chaperones
researchProduct

Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?

2015

International audience; Depression and diabetes are serious diseases with an increasing global prevalence. Intriguingly, recent meta-analyses have highlighted an asymmetrical relationship between the two conditions as depressed patients were found to display a higher risk of developing type 2 diabetes than those individuals suffering from diabetes are to become depressed. Based on recent findings, we favor a hypothesis where by decreased peripheral serotonin (5-HT) transporter (5-HTT) function is a reciprocal risk factor for the comorbidity of depression and diabetes, as it can trigger inflammatory pathogenetic mechanisms of both conditions. Higher intestinal levels of 5-HT and 5-HT3 recept…

Serotoninmedicine.medical_specialty5-HTAntidepressantComorbidityType 2 diabetesBehavioral NeuroscienceInsulin resistanceDiabetes mellitusInternal medicineAnimal models of depressionmedicineAnimalsHumansDepression (differential diagnoses)Serotonin Plasma Membrane Transport ProteinsInflammationIntestinal permeabilitybiologybusiness.industryDepressionInsulin resistancemedicine.diseaseAntidepressive AgentsReceptor InsulinEndotoxemia3. Good healthInsulin receptorEndocrinologyDiabetes Mellitus Type 2Immunologybiology.proteinAntidepressant[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Receptors Serotonin 5-HT3businessSignal Transduction
researchProduct

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

2003

Antidepressants are commonly supposed to enhance serotonergic and/or noradrenergic neurotransmission by inhibition of neurotransmitter reuptake through binding to the respective neurotransmitter transporters or through inhibition of the monoamine oxidase. Using the concentration-clamp technique and measurements of intracellular Ca2+, we demonstrate that different classes of antidepressants act as functional antagonists at the human 5-HT3A receptor stably expressed in HEK 293 cells and at endogenous 5-HT3 receptors of rat hippocampal neurons and N1E-115 neuroblastoma cells. The tricyclic antidepressants desipramine, imipramine, and trimipramine, the serotonin reuptake inhibitor fluoxetine, t…

Serotoninmedicine.medical_specialtySerotonin reuptake inhibitorMirtazapinePharmacologyKidneySerotonergicHippocampusNoradrenergic and specific serotonergic antidepressantCell LineMembrane PotentialsReuptakeNeuroblastomaCellular and Molecular NeuroscienceNorepinephrine reuptake inhibitorCell Line TumorInternal medicineDesipraminemedicineAnimalsHumansSerotonin 5-HT3 Receptor AntagonistsPharmacology (medical)Molecular BiologyNeuronsChemistryGeneral MedicineTrimipramineAntidepressive AgentsRatsPsychiatry and Mental healthEndocrinology5-HT6 receptorCalciumReceptors Serotonin 5-HT3medicine.drugPharmacopsychiatry
researchProduct

P-491 - Sensitivity to changes during antidepressant treatment: a comparison of unidimensional depression rating scales in patients with minor depres…

2012

In the efficacy evaluation of antidepressant treatments the total score of the Hamilton Depression Rating Scale (HAMD) is still regarded as the’gold standard’. Studies suggest that unidimensional subscales of the HAMD, which capture the core depressive symptoms, outperform the full HAMD regarding the detection of antidepressant treatment effects. The present study compared several unidimensional subscales of the HAMD and the Inventory of Depressive Symptomatology (IDS) regarding their sensitivity to changes in depression symptoms in a sample of patients with minor depression (MIND). Biweekly IDS-C28 and HAMD17 data from 287 patients of a 10-week randomised, placebo-controlled trial comparin…

Sertralinemedicine.medical_specialtymedicine.medical_treatmentShort scaleGroup psychotherapyPsychiatry and Mental healthRating scaleHamdmedicineAntidepressantIn patientPsychologyPsychiatryDepression (differential diagnoses)Clinical psychologymedicine.drugEuropean Psychiatry
researchProduct